CancerVAX, Inc. has raised $1.5M in total funding. The most recent round was Seed.
CancerVAX, Inc. is headquartered in Santa Barbara, CA.
Millions die each year because the body does not easily recognize and kill cancer cells, and other immunotherapies have had very limited success teaching the immune system to recognize cancer.
CancerVax is a pre-clinical biotech developing an AI-powered, injectable Universal Cancer Treatment Platform that detects, marks, and kills only cancer cells using the body's own immune system.
Instead of teaching the immune system to recognize cancer directly, their approach disguises cancer cells to look like a disease the body already recognizes (such as measles), 'tricking' the immune system into attacking them.
Founded by Ryan Davies in 2021 and led by CEO Byron Elton, the company has raised funds through equity crowdfunding on StartEngine.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.